Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

STSS - Sharps Technology Inc.


0.3129
0.000   -0.064%

Share volume: 3,333,831
Last Updated: Tue 04 Feb 2025 10:00:00 PM CET

PREVIOUS CLOSE
CHG
CHG%

$0.31
-0.01
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
-19.97%
1 Month
-85.78%
3 Months
-90.19%
6 Months
27.71%
1 Year
2.19%
2 Year
-78.86%
Key data
Stock price
$0.31
P/E Ratio 
0.00
DAY RANGE
$0.31 - $0.35
EPS 
-$0.15
52 WEEK RANGE
$0.13 - $4.16
52 WEEK CHANGE
$13.58
MARKET CAP 
4.297 M
YIELD 
N/A
SHARES OUTSTANDING 
28.591 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.43
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$7,169,933
AVERAGE 30 VOLUME 
$2,542,683
Company detail
CEO: Robert M. Hayes
Region: US
Website: sharpstechnology.com
Employees: 3
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Sharps Technology Inc. researches, designs, develops, manufactures, distributes, and sells safety syringe products. Sharps Provensa is an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Recent news